News
-
-
-
PRESS RELEASE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Applied DNA Sciences presents Linea IVT platform as a solution for improved mRNA production at 4th Annual mRNA-based Therapeutics Summit. The platform reduces dsRNA contamination -
PRESS RELEASE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Applied DNA Sciences, Inc. presents Linea IVT platform for enhanced mRNA production at 4th Annual mRNA-based Therapeutics Summit. Solution reduces dsRNA contamination, streamlines workflows, and boosts efficiency -
PRESS RELEASE
2024 Half-Year Results Financial Report URW N.V.
-
REGULATED PRESS RELEASE
Imerys-communiqué-de-presse-résultats-S1-2024-29-Juillet-2024-VFR
-
REGULATED PRESS RELEASE
Imerys-press-release-H1-2024-results-29-July-2024-VENG
-
-
-